Why Online Menopause Care Exploded in 2025 and 2026
Over 1 million women in the United States reach menopause each year, and the vast majority of them cannot find a local doctor with adequate menopause training. A 2025 American Medical Association survey found that 73 percent of ob-gyn residents received fewer than two hours of formal menopause education during their entire training. The result is a system where women are told their symptoms are “normal” and sent home without treatment, or prescribed birth control pills as a one-size-fits-all solution. Online menopause clinics have filled this gap — not because they are better than in-person care in an ideal world, but because the in-person system is failing most women.
Midi Health, the category leader, reached a 1 billion dollar valuation in early 2026, making it the first menopause-focused telehealth unicorn. CEO Joanna Strober stated that the company now handles over 100,000 patient visits per month across all 50 states. Winona, another major player, built its model around direct-to-consumer hormone testing and HRT prescriptions. The market has consolidated quickly: in late 2025, Midi acquired Evernow, another telehealth menopause provider, creating a combined patient base of over 350,000 women. The menopause treatment landscape has shifted permanently toward virtual care, and understanding the landscape of providers is now essential for any woman considering menopause treatment.
Not all platforms are equal. Some employ board-certified menopause specialists. Others use nurse practitioners or physician assistants working from standardized protocols. Some accept insurance; others are cash-only. Some prescribe the full range of HRT, including progesterone and testosterone, while others limit their formularies to the simplest options. The 2026 review landscape from Everyday Health and Flow Space lists 15 to 17 major platforms, but five dominate in terms of patient volume and quality of care: Midi Health, Winona, Allara Health, Hers, and Gala. The complete guide to menopause treatment options has a section on finding a provider that covers both in-person and telehealth pathways.
Midi Health: The Most Comprehensive Option
Midi Health operates in all 50 states and accepts most major insurance plans, which sets it apart from cash-only competitors. The platform connects patients with board-certified nurse practitioners, physician assistants, or physicians who complete a 40-hour NAMS menopause training program before being allowed to consult independently. Initial consultations run 45 minutes — substantially longer than the 15 minutes typical of an in-network ob-gyn visit. Follow-ups are 15 to 20 minutes. The cost for uninsured patients is 149 dollars for the initial visit and 99 dollars for follow-ups, with medication costs billed separately through insurance or GoodRx.
Midi’s formulary includes oral and transdermal estradiol, estradiol patches and gels, oral and vaginal progesterone, the Mirena IUD for progestin delivery, vaginal estrogen cream and tablets, and the Femring vaginal ring. They also prescribe Paroxetine 7.5 mg for women who cannot take estrogen. What they do not prescribe: compounded bioidentical hormones, testosterone for women (though they will refer to a specialist), or controlled substances like gabapentin off-label. Their 2025 clinical outcomes report, published on their website and audited by a third party, showed that 89 percent of patients had clinically significant hot flash reduction within 8 weeks, as measured by the validated MENQOL questionnaire.
Midi accepts insurance from Aetna, Cigna, Blue Cross Blue Shield (most plans), UnitedHealthcare, and several regional plans. For insured patients, the out-of-pocket cost is typically the standard specialist co-pay, ranging from 30 to 75 dollars per visit. The company reported in early 2026 that 85 percent of patients had insurance that covered at least part of their care. Midi also offers a same-week appointment availability in most states — compared to the 4-to-12-week wait for a menopause specialist in most metropolitan areas. The HRT complete guide includes a provider comparison section that covers the clinical training standards across different telehealth platforms.
Winona, Allara, and Hers: How They Compare
Winona operates on a membership model. The initial consultation is free, and patients pay a monthly fee of 20 to 80 dollars for the ongoing prescription management, plus medication costs filled through their partner pharmacy. Winona is known for offering bioidentical hormone pellets and compounded creams alongside FDA-approved products. This is both a strength and a concern: the compounded products are not FDA-approved and their potency can vary by up to 20 percent between batches. A 2024 investigation by The Markup found that Winona’s prescribing practices for compounded hormones did not always include a discussion of FDA-approved alternatives, which is a standard of care requirement. For FDA-approved products like Estradiol patches and Vagifem, Winona’s pricing is competitive, with three-month supplies starting at about 75 dollars for insured patients.
Allara Health takes a holistic approach that combines gynecology with nutrition and mental health support. Initial consultation costs 250 dollars including a comprehensive lab panel. They accept insurance from Aetna and Cigna and are expanding to additional plans in 2026. Allara is the best option for women who want a longer-term management plan rather than a quick prescription. Their 2025 patient survey, published on their site, reported that 78 percent of patients continued care beyond six months — well above the industry average of 55 percent for standalone telehealth services. Their weakness is availability: they operate in 45 states (not yet Alaska, Rhode Island, Idaho, Montana, or Wyoming) and have longer wait times for new patients in high-demand regions like California and New York.
Hers, owned by Hims & Hers, launched its menopause service in 2025 and has scaled rapidly. The model is simpler and cheaper: 99 dollars for the initial consultation, 30 to 100 dollars per month for medication, and no insurance billing — everything is cash-pay. The simplicity is appealing but the limitations are real. Hers does not prescribe vaginal rings or compounded products, and their prescribing is limited to oral medications and transdermal patches. They also do not offer progesterone-only prescriptions or the Mirena IUD. For women with straightforward symptoms and no complex medical history, Hers works. For women who need nuanced HRT management — especially combined HRT with progesterone — Midi or Allara are the better choice. The HRT options guide includes a provider recommendation algorithm based on your symptom complexity and insurance status.
What to Expect From Your First Telehealth Menopause Visit
The process is standardized across most platforms. You fill out a comprehensive health history questionnaire online, including your menstrual history, symptom inventory, medical conditions, medications, and family history of breast cancer, blood clots, and heart disease. The platform then matches you with a clinician who reviews your history before the video call. The first visit covers the same ground as an in-person consultation: symptom assessment, review of treatment options, discussion of risks and benefits, and a treatment plan. The difference is that the physical exam happens later — either through an in-person lab visit for blood work or through a mail-in hormone test kit.
Most platforms require blood pressure screening before prescribing oral estrogen, because hypertension is a relative contraindication. Some require a DEXA scan within the previous two years if you are over 50 or have risk factors for osteoporosis. If these are not available, the platform will send you to a local lab (Quest or LabCorp) for blood draws at no additional cost beyond your insurance co-pay. The online consultation cannot replace a pelvic exam or Pap smear — those still need to be done in person, and the platforms will remind you to stay current with your gynecologic screening.
The logistics are easier than most women expect. The video platform works on any smartphone, tablet, or computer with a camera. The prescription is sent electronically to the pharmacy of your choice or shipped by the platform’s partner pharmacy. Follow-ups are typically at 6 weeks, 12 weeks, and then every 6 months. Blood work for hormone levels is drawn at baseline and then annually unless symptoms change. Dr. Stephanie Faubion, NAMS medical director, stated in a 2025 webinar: “Telehealth menopause care is not inferior care. Studies comparing telehealth to in-person outcomes for menopause management show equivalent patient satisfaction and symptom improvement. The advantage of telehealth is accessibility, not quality.” The menopause symptoms guide has a pre-appointment preparation checklist that works equally well for telehealth and in-person visits.
Costs, Insurance Pitfalls, and When to Still See a Doctor in Person
The cash-pay cost for an initial telehealth menopause consultation ranges from 99 to 250 dollars. Follow-ups range from 49 to 99 dollars. Medication costs vary widely by platform and insurance status. On Midi with insurance, a three-month supply of generic estradiol patches costs about 30 to 60 dollars. On Hers without insurance, the same three-month supply costs 90 to 300 dollars. The platform comparison sites — Best Menopause Care (updated May 2026) and Everyday Health’s 2026 list — provide side-by-side pricing that accounts for these variables. The insurance trap to watch for: some plans cover the consultation but not the medication, or vice versa. Check both before committing to a platform.
Telehealth is not appropriate for every woman. You need an in-person visit if: you have undiagnosed vaginal bleeding, an abnormal Pap smear needs follow-up, you have a pelvic mass, or you need an IUD placed. Telehealth is also a poor fit for women who need comprehensive cardiovascular or metabolic evaluation before starting HRT. A 2025 analysis in Obstetrics & Gynecology of 1,200 telehealth menopause patients found that 12 percent were referred to an in-person specialist after their initial video visit for issues that could not be managed remotely — primarily abnormal bleeding, complex medical histories, and need for IUD insertion. Telehealth triages well but cannot replace every aspect of in-person care.
For women in rural areas or states with few menopause specialists, telehealth is transformative. A 2025 report from the University of Mississippi Medical Center found that telehealth menopause consultations increased the percentage of symptomatic women receiving evidence-based treatment from 14 percent to 67 percent in a two-year period. The technology gap — not having a reliable internet connection or a private space for the video call — remains a barrier for some women, but platforms are increasingly offering phone-only consultation options for these cases. The complete guide to menopause treatment options has a telehealth readiness checklist that helps you assess whether your medical needs can be met online before you book.